The National Institute for Occupational Safety and Health (NIOSH) offered free black lung screenings at Mylan Park on ...

Mylan NV said on Thursday it would reduce the out-of-pocket costs of its emergency EpiPen allergy injection for some patients amid a wave of criticism from lawmakers and the public over the ...

After inking a related patent settlement last year, Viatris has cleared another obstacle in its quest to launch generic ...

Mylan NV <MYL.O> has finalized a $465 million settlement resolving U.S. Justice Department claims it overcharged the government for its EpiPen emergency allergy treatment, which became the center ...

A mobile unit that provides free black lung screenings to coal miners is up and running again this month after federal cuts ...

A federal court ruled in Mylan's favor, finding no infringement of Novo's patent tied to Wegovy, rejecting direct, ...

The move, which brings blockbuster treatments Viagra and Lipitor under one umbrella with Mylan's EpiPen, is part of a years-long effort by Pfizer to split into three parts - innovative medicines, ...

Mylan made $1.1 billion in revenue per year from EpiPen sales (though that may be decreasing with the introduction of new competition, including CVS’s generic auto-injector).

Mylan NV is poised to lose its hostile bid for Perrigo Co., people familiar with the matter said, a rare outcome in one of the bitterest takeover battles in decades.

Mylan’s silence speaks volumes. By failing to disclose the voting results during today’s shareowner meeting, Mylan’s board telegraphed that directors faced strong opposition.

Mylan, the profiteering, tax-dodging drug company currently taking immense heat for jacking up the price of its Epipen by 500%, announced Thursday that it will help more patients cover their ...

Mylan NV, whose price increases on its lifesaving EpiPen drug drew broad criticism this month, said Monday it would launch a half-priced generic version of the medicine—in effect, competing ...